Curriculum Vitae
PART I: General Information
DATE PREPARED:
August 10, 2001
Name:
Wesley P. Fairfield, M.D.
Office Address:
Neuroendocrine Unit, BUL-457B
Massachusetts General Hospital
Boston, Massachusetts 02114-2696
E-mail: wfairfield@partners.org
Fax: (617) 726-5072
Place of Birth:
Biddeford, Maine
Education:
1990
A.B.
Bowdoin College
Brunswick, Maine
1995
M.D.
Harvard Medical School
Boston, Massachusetts
Postdoctoral Training:
1995-1996
Internship
Internal Medicine
Massachusetts General Hospital
Boston, Massachusetts
1996-1998
Residency
Internal Medicine
Massachusetts General Hospital
Boston, Massachusetts
1998-1999
Clinical Fellowship
Endocrinology
Massachusetts General Hospital
Boston, Massachusetts
1999-2001
Research Fellowship
Neuroendocrinology
Massachusetts General Hospital
Boston, Massachusetts
Licensure and Certification:
August 1997
Commonwealth of Massachusetts, Board of Registration in Medicine
November 1998
ABIM Certification, Internal Medicine
November 2000
ABIM Certification, Endocrinology & Metabolism
Academic Appointments:
1995-1998
Clinical Fellow in Medicine
Harvard Medical School
Boston, Massachusetts
1998-2001
Research Fellow in Medicine
Harvard Medical School
Boston, Massachusetts
2001-
Instructor in Medicine
Harvard Medical School
Boston, Massachusetts
W. P. Fairfield
Hospital Appointments:
1998-2000
Clinical and Research Fellow in Medicine
Massachusetts General Hospital
Boston, Massachusetts
1999-
Consultant in Medicine, Associate Staff
Massachusetts Eye & Ear Infirmary
Boston, Massachusetts
2000-
Assistant in Medicine
Massachusetts General Hospital
Boston, Massachusetts
Major Administrative Responsibilities:
1999-
Clinical Conference Coordinator
Neuroendocrine Unit
Massachusetts General Hospital
Boston, Massachusetts
2000-
Clinical Fellows Computer Orientation
Neuroendocrine Unit
Massachusetts General Hospital
Boston, Massachusetts
Professional Societies:
1998-
The Endocrine Society
Member
1991-
Massachusetts Medical Society
Member
1991-
American Medical Association
Member
Awards and Honors:
Bowdoin College
1990
Magna cum laude Graduate
1990
Summa cum laude, Biology Departmental Honors
Massachusetts General Hospital
1999
The Endocrine Society Travel Grant Recipient
Postgraduate Course on GH and Growth Factors - Metabolic Disorders
Marstrand, Sweden
2000
Recipient, National Research Service Award, National Institutes of Health
2001
The Endocrine Society Travel Grant Award, Denver, Colorado
PART II: Research, Teaching, and Clinical Contributions
A. Narrative report of Research, Teaching, and Clinical Contributions
My research focus stems from an interest in the neuroendocrine controls of body
composition. I have trained as a research fellow under the tutelage of Dr. Anne Klibanski,
Professor of Medicine at Harvard Medical School and Chief of the Neuroendocrine Unit. I have
designed and implemented clinical trials investigating the physiology of glucocorticoid induced
osteopenia and sarcopenia and the interactions with the growth hormone/IGF-I axis.
As a staff physician in the Neuroendocrine Unit at Massachusetts General Hospital, I
supervise and teach students, residents and clinical fellows. The Neuroendocrine Clinical Center
attracts a variety of patients with pituitary diseases from all over the world. Teaching in the
ambulatory setting is predominantly one-on-one and the experience is enriched by exposure to
2
W. P. Fairfield
many different rare and fascinating disorders in the field of neuroendocrinology. In addition,
neuroendocrine consultations for inpatients provides another venue in which I supervise and teach
students, residents (medicine and surgery) and fellows about inpatient neuroendocrinology.
B. Funding Information
1998-2000
NIH, Institutional NRSA
PI: Joseph Avruch, M.D.
5 T32 DK07028-25
Training Program in Diabetes, Endocrinology and Metabolism
2000-2002
NIH, Individual NRSA
PI: Wesley P. Fairfield, M.D. 1 F32 DK10122-01
IGF-I/BP-3 in glucocorticoid osteopenia and sarcopenia
C. Report of Current Research Activities
Mechanisms of glucocorticoid sarcopenia and osteopenia
Investigator
Interaction between glucocorticoids and GH/IGF-I axis
Investigator
Bone markers after GH receptor antagonist in acromegaly
Investigator
Cardiovascular risk in Crohn’s patients taking glucocorticoids
Investigator
D. Report of Teaching
1. Local contributions
a. Harvard Medical School
1994-1995
Introduction to clinical medicine, Tutor
2 students, 4 hr/wk
12 months
1995
Introduction to clinical medicine, OSCE Evaluator
50 students, 6 hrs
Two sessions
1998-1999
Patient Doctor I, Seminar on thyroid examination
50 students, 4 hrs
Annual session
1999-
Patient Doctor II, Clinical Preceptor
2 students, 4 hr/wk
2 months/yr
e. Advisory and supervisory responsibilities in clinical or laboratory setting
2000
PASTEUR Clinical Research Program, Mentor
Supervised 1 student working 40 hrs/wk
3 months/yr
2001
GCRC Summer Clinical Research Program, Mentor
Supervised 1 student working 40 hrs/wk
3 months/yr
3
W. P. Fairfield
2000-
Preceptor, Neuroendocrine Clinical Center
Supervised fellows and residents
40 hrs/year
PART III: Bibliography
Original Articles
Dickinson PS, Fairfield WP, Hetling JR, Hauptman J. Neurotransmitter interactions in the
stomatogastric system of the spiny lobster: one peptide alters the response of a central
pattern generator to a second peptide. J Neurophysiol 77 (2): 599-610, 1997.
Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon S. Osteopenia in eugonadal men with
AIDS wasting syndrome. J Clin Endocrinol Metab 86(5): 2020-2026, 2001.
Fairfield WP, Treat M, Rosenthal DI, Frontera W, Stanley T, Corcoran C, Costello M, Parlman K,
Schoenfeld D, Klibanski A, Grinspoon S. Effects of testosterone and exercise upon regional
body composition and muscle leanness in eugonadal men with AIDS wasting. J Applied
Phys 90(6): 2166-2171, 2001.
Reviews, Chapters, and Editorials
Soyka LA, Fairfield WP, Klibanski A. Clinical review 117: Hormonal determinants and
disorders of peak bone mass in children. J Clin Endocrinol Metab 85(11): 3951-63, 2000.
Thesis
Fairfield WP. Analysis of a contingent interaction between red pigment concentrating hormone
and proctolin in the stomatogastric nervous system of the spiny lobster. Department of
Biology, Bowdoin College, Brunswick, ME, 1990.
Educational Material
Fairfield WP. Neurocognitive dysfunction in patients with pituitary adenomas. MGH
Neuroendocrine Clinical Center Bulletin 1999; 5(1): 4-7.
Abstracts
Cagliero E, Fairfield WP, Nathan DM. Quality of care provided to type 2 diabetic patients by
endocrinologists and internists. American Diabetes Association Scientific Sessions,
1997.
Fairfield WP, Berger LK, Klibanski A. Glucocorticoids decrease bone formation markers in
healthy young women. The Endocrine Society 83rd Annual Meeting, Denver, CO, 2001.
Fairfield WP, Sesmilo G, Katznelson L, Klibanski A. Effects of serum IGF-I normalization with a
GH receptor antagonist on bone markers in acromegaly. The Endocrine Society 83rd
Annual Meeting. Denver, CO, 2001.
4